Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-01-04 @ 8:51 AM
Study NCT ID:
NCT05678959
Status:
TERMINATED
Last Update Posted:
2025-10-30
First Post:
2023-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Extension Study of Ligelizumab in Food Allergy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-09
First Submit QC Date:
None
Study First Post Date:
2023-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-28
Results First Submit QC Date:
None
Results First Post Date:
2025-10-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21
Last Update Post Date:
2025-10-30
Last Update Post Date Type:
ESTIMATED